Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Psychol Med

Retrieve available abstracts of 133 articles:
HTML format
Text format



Single Articles


    October 2017
  1. MUCCI A, Galderisi S, Green MF, Nuechterlein K, et al
    Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Psychol Med. 2017 Oct 11:1-10. doi: 10.1017/S0033291717002902.
    PubMed     Text format     Abstract available


  2. XIE DJ, Lui SSY, Geng FL, Yang ZY, et al
    Dissociation between affective experience and motivated behaviour in schizophrenia patients and their unaffected first-degree relatives and schizotypal individuals.
    Psychol Med. 2017 Oct 11:1-13. doi: 10.1017/S0033291717002926.
    PubMed     Text format     Abstract available


  3. AAS M, Melle I, Bettella F, Djurovic S, et al
    Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not.
    Psychol Med. 2017 Oct 2:1-7. doi: 10.1017/S0033291717001209.
    PubMed     Text format     Abstract available


    September 2017
  4. LU Y, Pouget JG, Andreassen OA, Djurovic S, et al
    Genetic risk scores and family history as predictors of schizophrenia in Nordic registers.
    Psychol Med. 2017 Sep 25:1-9. doi: 10.1017/S0033291717002665.
    PubMed     Text format     Abstract available


  5. DONOHOE G, Dillon R, Hargreaves A, Mothersill O, et al
    Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial.
    Psychol Med. 2017 Sep 21:1-14. doi: 10.1017/S0033291717001982.
    PubMed     Text format     Abstract available


  6. GAUGHRAN F, Lally J, Beck K, McCormack R, et al
    Brain-relevant antibodies in first-episode psychosis: a matched case-control study.
    Psychol Med. 2017 Sep 18:1-9. doi: 10.1017/S0033291717002689.
    PubMed     Text format     Abstract available


  7. TIN LNW, Lui SSY, Ho KKY, Hung KSY, et al
    High-functioning autism patients share similar but more severe impairments in verbal theory of mind than schizophrenia patients.
    Psychol Med. 2017 Sep 18:1-12. doi: 10.1017/S0033291717002690.
    PubMed     Text format     Abstract available


  8. CULBRETH AJ, Moran EK, Barch DM
    Effort-cost decision-making in psychosis and depression: could a similar behavioral deficit arise from disparate psychological and neural mechanisms?
    Psychol Med. 2017 Sep 11:1-16. doi: 10.1017/S0033291717002525.
    PubMed     Text format     Abstract available


  9. SCHULTZE-LUTTER F, Michel C, Ruhrmann S, Schimmelmann BG, et al
    Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community.
    Psychol Med. 2017 Sep 11:1-15. doi: 10.1017/S0033291717002586.
    PubMed     Text format     Abstract available


  10. REEDER C, Huddy V, Cella M, Taylor R, et al
    A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial.
    Psychol Med. 2017 Sep 4:1-11. doi: 10.1017/S0033291717001234.
    PubMed     Text format     Abstract available


    August 2017
  11. CURTIS D, Derks EM
    Letter to the Editor: Schizophrenia does not represent the extreme of a normally distributed trait.
    Psychol Med. 2017 Aug 29:1-2. doi: 10.1017/S0033291717002422.
    PubMed     Text format    


  12. BORA E
    Letter to the Editor: The half-alive concept of schizophrenia is still better than the spectrum of everything.
    Psychol Med. 2017 Aug 29:1-2. doi: 10.1017/S0033291717002446.
    PubMed     Text format    


  13. LEROY A, Petyt G, Pignon B, Vaiva G, et al
    Research Letter: Auto-activation deficit in schizophrenia: a case report.
    Psychol Med. 2017 Aug 24:1-3. doi: 10.1017/S0033291717002252.
    PubMed     Text format    


  14. DEGNAN A, Baker S, Edge D, Nottidge W, et al
    The nature and efficacy of culturally-adapted psychosocial interventions for schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2017 Aug 23:1-14. doi: 10.1017/S0033291717002264.
    PubMed     Text format     Abstract available


  15. SERPA MH, Doshi J, Erus G, Chaim-Avancini TM, et al
    State-dependent microstructural white matter changes in drug-naive patients with first-episode psychosis.
    Psychol Med. 2017 Aug 22:1-15. doi: 10.1017/S0033291717001015.
    PubMed     Text format     Abstract available


  16. DIMITRAKOPOULOS S, Vitoratou S, Mougiakos T, Bogeas N, et al
    Steinberg and Durell (1968) revisited: increased rates of First Episode Psychosis following military induction in Greek Army Recruits.
    Psychol Med. 2017 Aug 22:1-9. doi: 10.1017/S0033291717002276.
    PubMed     Text format     Abstract available


  17. BOUSMAN CA, Cropley V, Klauser P, Hess JL, et al
    Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia.
    Psychol Med. 2017 Aug 22:1-9. doi: 10.1017/S0033291717002173.
    PubMed     Text format     Abstract available


  18. CURTIS D
    Association between smoking and psychosis may be mediated by maternal smoking during pregnancy.
    Psychol Med. 2017 Aug 14:1. doi: 10.1017/S0033291717002240.
    PubMed     Text format    


  19. HUANG X, Fox KR, Ribeiro JD, Franklin JC, et al
    Psychosis as a risk factor for suicidal thoughts and behaviors: a meta-analysis of longitudinal studies.
    Psychol Med. 2017 Aug 14:1-12. doi: 10.1017/S0033291717002136.
    PubMed     Text format     Abstract available


  20. REICHERT A, Jacobs R
    Socioeconomic inequalities in duration of untreated psychosis: evidence from administrative data in England.
    Psychol Med. 2017 Aug 14:1-12. doi: 10.1017/S0033291717002197.
    PubMed     Text format     Abstract available


    July 2017
  21. RUS-CALAFELL M, Garety P, Sason E, Craig TJK, et al
    Virtual reality in the assessment and treatment of psychosis: a systematic review of its utility, acceptability and effectiveness.
    Psychol Med. 2017 Jul 24:1-30. doi: 10.1017/S0033291717001945.
    PubMed     Text format     Abstract available


  22. MOLLON J, Reichenberg A
    Cognitive development prior to onset of psychosis.
    Psychol Med. 2017 Jul 24:1-12. doi: 10.1017/S0033291717001970.
    PubMed     Text format     Abstract available


  23. DREIER JW, Berg-Beckhoff G, Andersen AMN, Susser E, et al
    Fever and infections during pregnancy and psychosis-like experiences in the offspring at age 11. A prospective study within the Danish National Birth Cohort.
    Psychol Med. 2017 Jul 24:1-11. doi: 10.1017/S0033291717001805.
    PubMed     Text format     Abstract available


  24. FIRTH J, Stubbs B, Sarris J, Rosenbaum S, et al
    The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis - CORRIGENDUM.
    Psychol Med. 2017 Jul 17:1. doi: 10.1017/S0033291717001866.
    PubMed     Text format    


  25. JEPSEN JRM, Rydkjaer J, Fagerlund B, Pagsberg AK, et al
    Overlapping and disease specific trait, response, and reflection impulsivity in adolescents with first-episode schizophrenia spectrum disorders or attention-deficit/hyperactivity disorder.
    Psychol Med. 2017 Jul 17:1-13. doi: 10.1017/S0033291717001921.
    PubMed     Text format     Abstract available


  26. GULOKSUZ S, van Os J
    The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum.
    Psychol Med. 2017 Jul 10:1-16. doi: 10.1017/S0033291717001775.
    PubMed     Text format     Abstract available


    June 2017
  27. PAKSARIAN D, Trabjerg BB, Merikangas KR, Mors O, et al
    The role of genetic liability in the association of urbanicity at birth and during upbringing with schizophrenia in Denmark.
    Psychol Med. 2017 Jun 29:1-10. doi: 10.1017/S0033291717001696.
    PubMed     Text format     Abstract available


  28. CUI Y, Liu B, Song M, Lipnicki DM, et al
    Auditory verbal hallucinations are related to cortical thinning in the left middle temporal gyrus of patients with schizophrenia.
    Psychol Med. 2017 Jun 19:1-8. doi: 10.1017/S0033291717001520.
    PubMed     Text format     Abstract available


  29. BORA E, Ozerdem A
    Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia.
    Psychol Med. 2017 Jun 6:1-14. doi: 10.1017/S0033291717001490.
    PubMed     Text format     Abstract available


    May 2017
  30. WALTON E, Hibar DP, van Erp TGM, Potkin SG, et al
    Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium.
    Psychol Med. 2017 May 26:1-13. doi: 10.1017/S0033291717001283.
    PubMed     Text format     Abstract available


  31. ZHENG W, Li XH, Yang XH, Cai DB, et al
    Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Psychol Med. 2017 May 22:1-10. doi: 10.1017/S0033291717001271.
    PubMed     Text format     Abstract available


  32. DI BIASE MA, Cropley VL, Baune BT, Olver J, et al
    White matter connectivity disruptions in early and chronic schizophrenia.
    Psychol Med. 2017 May 22:1-14. doi: 10.1017/S0033291717001313.
    PubMed     Text format     Abstract available


  33. MORITZ S, Klein JP, Desler T, Lill H, et al
    Neurocognitive deficits in schizophrenia. Are we making mountains out of molehills?
    Psychol Med. 2017 May 9:1-11. doi: 10.1017/S0033291717000939.
    PubMed     Text format     Abstract available


  34. BORA E, Binnur Akdede B, Alptekin K
    Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis.
    Psychol Med. 2017 May 4:1-14. doi: 10.1017/S0033291717000952.
    PubMed     Text format     Abstract available


  35. KRAKAUER K, Ebdrup BH, Glenthoj BY, Raghava JM, et al
    Patterns of white matter microstructure in individuals at ultra-high-risk for psychosis: associations to level of functioning and clinical symptoms.
    Psychol Med. 2017 May 3:1-19. doi: 10.1017/S0033291717001210.
    PubMed     Text format     Abstract available


  36. ALDERSON HL, Semple DM, Blayney C, Queirazza F, et al
    Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study.
    Psychol Med. 2017 May 3:1-8. doi: 10.1017/S0033291717001118.
    PubMed     Text format     Abstract available


  37. LEES J, Michalopoulou PG, Lewis SW, Preston S, et al
    Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial.
    Psychol Med. 2017 May 3:1-11. doi: 10.1017/S0033291717000885.
    PubMed     Text format     Abstract available


    April 2017
  38. ORANJE B, Aggernaes B, Rasmussen H, Ebdrup BH, et al
    Selective attention and mismatch negativity in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy.
    Psychol Med. 2017 Apr 26:1-11. doi: 10.1017/S0033291717000599.
    PubMed     Text format     Abstract available


  39. PAN YJ, Yeh LL, Chan HY, Chang CK, et al
    Transformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan.
    Psychol Med. 2017 Apr 26:1-11. doi: 10.1017/S0033291717001040.
    PubMed     Text format     Abstract available


  40. SPENCER BWJ, Shields G, Gergel T, Hotopf M, et al
    Diversity or disarray? A systematic review of decision-making capacity for treatment and research in schizophrenia and other non-affective psychoses.
    Psychol Med. 2017 Apr 26:1-17. doi: 10.1017/S0033291717000502.
    PubMed     Text format     Abstract available


  41. PARELLADA M, Pina-Camacho L, Moreno C, Aleman Y, et al
    Insular pathology in young people with high-functioning autism and first-episode psychosis.
    Psychol Med. 2017 Apr 24:1-11. doi: 10.1017/S0033291717000988.
    PubMed     Text format     Abstract available


  42. OUELLET-PLAMONDON C, Abdel-Baki A, Salvat E, Potvin S, et al
    Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Psychol Med. 2017 Apr 20:1-11. doi: 10.1017/S0033291717000976.
    PubMed     Text format     Abstract available


  43. VERMEULEN J, van Rooijen G, Doedens P, Numminen E, et al
    Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis.
    Psychol Med. 2017 Apr 11:1-12. doi: 10.1017/S0033291717000873.
    PubMed     Text format     Abstract available


  44. DEMJAHA A, Lappin JM, Stahl D, Patel MX, et al
    Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
    Psychol Med. 2017 Apr 11:1-9. doi: 10.1017/S0033291717000435.
    PubMed     Text format     Abstract available


  45. KNAPP F, Viechtbauer W, Leonhart R, Nitschke K, et al
    Planning performance in schizophrenia patients: a meta-analysis of the influence of task difficulty and clinical and sociodemographic variables.
    Psychol Med. 2017 Apr 7:1-15. doi: 10.1017/S0033291717000459.
    PubMed     Text format     Abstract available


  46. CHIEN WT, Bressington D, Yip A, Karatzias T, et al
    An international multi-site, randomized controlled trial of a mindfulness-based psychoeducation group programme for people with schizophrenia.
    Psychol Med. 2017 Apr 4:1-16. doi: 10.1017/S0033291717000526.
    PubMed     Text format     Abstract available


    March 2017
  47. EMSLEY R, Asmal L, du Plessis S, Chiliza B, et al
    Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.
    Psychol Med. 2017 Mar 28:1-10. doi: 10.1017/S0033291717000642.
    PubMed     Text format     Abstract available


  48. BRUCATO G, Masucci MD, Arndt LY, Ben-David S, et al
    Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.
    Psychol Med. 2017 Mar 2:1-13. doi: 10.1017/S0033291717000319.
    PubMed     Text format     Abstract available


    February 2017
  49. VAN RHEENEN TE, Lewandowski KE, Tan EJ, Ospina LH, et al
    Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum.
    Psychol Med. 2017 Feb 28:1-17. doi: 10.1017/S0033291717000307.
    PubMed     Text format     Abstract available


  50. FIRTH J, Stubbs B, Sarris J, Rosenbaum S, et al
    The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2017 Feb 16:1-13. doi: 10.1017/S0033291717000022.
    PubMed     Text format     Abstract available


  51. GRONHOLM PC, Thornicroft G, Laurens KR, Evans-Lacko S, et al
    Mental health-related stigma and pathways to care for people at risk of psychotic disorders or experiencing first-episode psychosis: a systematic review.
    Psychol Med. 2017 Feb 15:1-13. doi: 10.1017/S0033291717000344.
    PubMed     Text format     Abstract available


  52. RHINDRESS K, Robinson DG, Gallego JA, Wellington R, et al
    Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis.
    Psychol Med. 2017 Feb 14:1-13. doi: 10.1017/S0033291717000137.
    PubMed     Text format     Abstract available


  53. XU Y, Qin W, Zhuo C, Xu L, et al
    Selective functional disconnection of the orbitofrontal subregions in schizophrenia.
    Psychol Med. 2017 Feb 10:1-10. doi: 10.1017/S0033291717000101.
    PubMed     Text format     Abstract available


  54. NIELSEN SM, Toftdahl NG, Nordentoft M, Hjorthoj C, et al
    Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study.
    Psychol Med. 2017 Feb 7:1-10. doi: 10.1017/S0033291717000162.
    PubMed     Text format     Abstract available


  55. OCHOA S, Lopez-Carrilero R, Barrigon ML, Pousa E, et al
    Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis.
    Psychol Med. 2017 Feb 7:1-12. doi: 10.1017/S0033291716003421.
    PubMed     Text format     Abstract available


    January 2017
  56. STONE J, Koychev I, Reilly T, McGuire P, et al
    Reply to: Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Psychol Med. 2017 Jan 23:1. doi: 10.1017/S0033291716003470.
    PubMed     Text format    


  57. WOOLLEY JD, Chuang B, Fussell C, Scherer S, et al
    Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls.
    Psychol Med. 2017 Jan 16:1-12. doi: 10.1017/S0033291716003433.
    PubMed     Text format     Abstract available


  58. STUDERUS E, Ramyead A, Riecher-Rossler A
    Prediction of transition to psychosis in patients with a clinical high risk for psychosis: a systematic review of methodology and reporting.
    Psychol Med. 2017 Jan 16:1-16. doi: 10.1017/S0033291716003494.
    PubMed     Text format     Abstract available


  59. IWABUCHI SJ, Palaniyappan L
    Abnormalities in the effective connectivity of visuothalamic circuitry in schizophrenia.
    Psychol Med. 2017 Jan 12:1-11. doi: 10.1017/S0033291716003469.
    PubMed     Text format     Abstract available


    December 2016
  60. BORA E, Akdede BB, Alptekin K
    The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis.
    Psychol Med. 2016 Dec 29:1-11. doi: 10.1017/S0033291716003366.
    PubMed     Text format     Abstract available


  61. LIU M, Malone SM, Vaidyanathan U, Keller MC, et al
    Psychophysiological endophenotypes to characterize mechanisms of known schizophrenia genetic loci.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  62. MAIA-DE-OLIVEIRA JP, Baker GB, Dursun SM, Hallak JE, et al
    Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Psychol Med. 2016.
    PubMed     Text format    


  63. GAGE SH, Jones HJ, Burgess S, Bowden J, et al
    Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  64. STILO SA, Gayer-Anderson C, Beards S, Hubbard K, et al
    Further evidence of a cumulative effect of social disadvantage on risk of psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    November 2016
  65. WU C, Zheng Y, Li J, Wu H, et al
    Brain substrates underlying auditory speech priming in healthy listeners and listeners with schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  66. RAPADO-CASTRO M, Dodd S, Bush AI, Malhi GS, et al
    Cognitive effects of adjunctive N-acetyl cysteine in psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  67. CHANG WC, Kwong VW, Hui CL, Chan SK, et al
    Relationship of amotivation to neurocognition, self-efficacy and functioning in first-episode psychosis: a structural equation modeling approach.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  68. KLAAS HS, Clemence A, Marion-Veyron R, Antonietti JP, et al
    Insight as a social identity process in the evolution of psychosocial functioning in the early phase of psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  69. LANGE EH, Nerland S, Jorgensen KN, Morch-Johnsen L, et al
    Alcohol use is associated with thinner cerebral cortex and larger ventricles in schizophrenia, bipolar disorder and healthy controls.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  70. MCHUGH MJ, McGorry PD, Yung AR, Lin A, et al
    Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    October 2016
  71. RYDKJAER J, Mollegaard Jepsen JR, Pagsberg AK, Fagerlund B, et al
    Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  72. SHAH C, Zhang W, Xiao Y, Yao L, et al
    Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  73. RIKANDI E, Pamilo S, Mantyla T, Suvisaari J, et al
    Precuneus functioning differentiates first-episode psychosis patients during the fantasy movie Alice in Wonderland.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  74. VEERMAN SR, Schulte PF, Deijen JB, de Haan L, et al
    Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  75. PRUESSNER M, Bechard-Evans L, Pira S, Joober R, et al
    Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  76. SCHMIDT A, Antoniades M, Allen P, Egerton A, et al
    Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  77. ROCCA P, Galderisi S, Rossi A, Bertolino A, et al
    Social cognition in people with schizophrenia: a cluster-analytic approach.
    Psychol Med. 2016;46:2717-29.
    PubMed     Text format     Abstract available


    September 2016
  78. STONE JM, Morrison PD, Koychev I, Gao F, et al
    The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  79. STEEL C, Hardy A, Smith B, Wykes T, et al
    Cognitive-behaviour therapy for post-traumatic stress in schizophrenia. A randomized controlled trial.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  80. FRAJO-APOR B, Kemmler G, Pardeller S, Plass T, et al
    Emotional intelligence and non-social cognition in schizophrenia and bipolar I disorder.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  81. VELING W, Counotte J, Pot-Kolder R, van Os J, et al
    Childhood trauma, psychosis liability and social stress reactivity: a virtual reality study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  82. LALLY J, Ajnakina O, Di Forti M, Trotta A, et al
    Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  83. FISZDON JM, Choi KH, Bell MD, Choi J, et al
    Cognitive remediation for individuals with psychosis: efficacy and mechanisms of treatment effects.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  84. CHEN DC, Du XD, Yin GZ, Yang KB, et al
    Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  85. O'REILLY K, O'Connell P, Donohoe G, Coyle C, et al
    Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  86. RINGEN PA, Nesvag R, Helle S, Lagerberg TV, et al
    Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  87. HODGINS S, Larm P, Westerman J
    Individuals developing schizophrenia are hidden among adolescent substance misusers.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    July 2016
  88. PERALTA V, Cuesta MJ
    Delusional disorder and schizophrenia: a comparative study across multiple domains.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  89. RENTZSCH J, Koller K, Kronenberg G
    Letter to the Editor: Disentangling cause and effect in the relationship between cannabis and psychosis: are we there yet?
    Psychol Med. 2016.
    PubMed     Text format    


  90. MIKOLAS P, Melicher T, Skoch A, Matejka M, et al
    Connectivity of the anterior insula differentiates participants with first-episode schizophrenia spectrum disorders from controls: a machine-learning study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  91. RIMVALL MK, Clemmensen L, Munkholm A, Rask CU, et al
    Introducing the White Noise task in childhood: associations between speech illusions and psychosis vulnerability.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  92. REININGHAUS U, Gayer-Anderson C, Valmaggia L, Kempton MJ, et al
    Psychological processes underlying the association between childhood trauma and psychosis in daily life: an experience sampling study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  93. WANG C, Ji F, Hong Z, Poh JS, et al
    Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    June 2016
  94. FINEBERG SK, Leavitt J, Deutsch-Link S, Dealy S, et al
    Self-reference in psychosis and depression: a language marker of illness.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  95. HU M, Zong X, Zheng J, Mann JJ, et al
    Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  96. HUI CL, Li YK, Li AW, Lee EH, et al
    Visual working memory deterioration preceding relapse in psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  97. DE BONT PA, van den Berg DP, van der Vleugel BM, de Roos C, et al
    Prolonged exposure and EMDR for PTSD v. a PTSD waiting-list condition: effects on symptoms of psychosis, depression and social functioning in patients with chronic psychotic disorders.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  98. BERGINK V, Laursen TM, Johannsen BM, Kushner SA, et al
    Letter to the Editor: Postpartum psychosis and pre-eclamptic toxaemia: a reply.
    Psychol Med. 2016.
    PubMed     Text format    


  99. CHEN LJ, Steptoe A, Chung MS, Ku PW, et al
    Association between actigraphy-derived physical activity and cognitive performance in patients with schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  100. BROCKINGTON I
    Letter to the Editor Postpartum psychosis and pre-eclamptic toxaemia.
    Psychol Med. 2016.
    PubMed     Text format    


  101. JUNG E, Wiesjahn M, Wendt H, Bock T, et al
    Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  102. HARING L, Muursepp A, Mottus R, Ilves P, et al
    Cortical thickness and surface area correlates with cognitive dysfunction among first-episode psychosis patients.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  103. GUO S, Palaniyappan L, Liddle PF, Feng J, et al
    Dynamic cerebral reorganization in the pathophysiology of schizophrenia: a MRI-derived cortical thickness study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  104. BAKKER G, Caan MW, Schluter RS, Bloemen OJ, et al
    Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  105. LEE EH, Hui CL, Chang WC, Chan SK, et al
    Letter to the Editor: Comparison of cognitive functions, pre-morbid conditions and clinical characteristics between brief psychotic disorder and schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format    


  106. O'DONOGHUE B, Lyne JP, Renwick L, Lane A, et al
    Neighbourhood characteristics and the incidence of first-episode psychosis and duration of untreated psychosis.
    Psychol Med. 2016;46:1367-78.
    PubMed     Text format     Abstract available


    April 2016
  107. CABRERA B, Bioque M, Penades R, Gonzalez-Pinto A, et al
    Cognition and psychopathology in first-episode psychosis: are they related to inflammation?
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  108. KIMHY D, Gill KE, Brucato G, Vakhrusheva J, et al
    The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  109. JORGENSEN KN, Nerland S, Norbom LB, Doan NT, et al
    Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  110. VEERMAN SR, Schulte PF, Smith JD, de Haan L, et al
    Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  111. CROSSLEY NA, Fox PT, Bullmore ET
    Meta-connectomics: human brain network and connectivity meta-analyses.
    Psychol Med. 2016;46:897-907.
    PubMed     Text format     Abstract available


    March 2016
  112. MORGAN C, John S, Esan O, Hibben M, et al
    The incidence of psychoses in diverse settings, INTREPID (2): a feasibility study in India, Nigeria, and Trinidad.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  113. VAN OMMEN MM, van Beilen M, Cornelissen FW, Smid HG, et al
    The prevalence of visual hallucinations in non-affective psychosis, and the role of perception and attention.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  114. ISING HK, Ruhrmann S, Burger NA, Rietdijk J, et al
    Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  115. WANG Q, Cheng W, Li M, Ren H, et al
    The CHRM3 gene is implicated in abnormal thalamo-orbital frontal cortex functional connectivity in first-episode treatment-naive patients with schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  116. RIGUCCI S, Marques TR, Di Forti M, Taylor H, et al
    Effect of high-potency cannabis on corpus callosum microstructure.
    Psychol Med. 2016;46:841-54.
    PubMed     Text format     Abstract available


    February 2016
  117. FORTGANG RG, Hultman CM, van Erp TG, Cannon TD, et al
    Multidimensional assessment of impulsivity in schizophrenia, bipolar disorder, and major depressive disorder: testing for shared endophenotypes.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  118. FETT AJ, Shergill SS, Korver-Nieberg N, Yakub F, et al
    Learning to trust: trust and attachment in early psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    January 2016
  119. PU W, Luo Q, Palaniyappan L, Xue Z, et al
    Failed cooperative, but not competitive, interaction between large-scale brain networks impairs working memory in schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    December 2015
  120. BEGEMANN MJ, Daalman K, Heringa SM, Schutte MJ, et al
    Letter to the Editor: Childhood trauma as a risk factor for psychosis: the confounding role of cognitive functioning.
    Psychol Med. 2015.
    PubMed     Text format    


  121. HUI CL, Lee EH, Chang WC, Chan SK, et al
    Letter to the Editor: Comparing delusional disorder and schizophrenia: a comment on Hui et al. (2015) - a reply.
    Psychol Med. 2015.
    PubMed     Text format    


  122. PERALTA V, Cuesta MJ
    Letter to the Editor: Comparing delusional disorder and schizophrenia: a comment on Hui et al. (2015).
    Psychol Med. 2015.
    PubMed     Text format    


  123. GERSTENBERG M, Theodoridou A, Traber-Walker N, Franscini M, et al
    Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  124. FONSECA-PEDRERO E, Debbane M, Schneider M, Badoud D, et al
    Schizotypal traits in adolescents with 22q11.2 deletion syndrome: validity, reliability and risk for psychosis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  125. BIANCONI F, Bonomo M, Marconi A, Kolliakou A, et al
    Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  126. BARKER V, Bois C, Johnstone EC, Owens DG, et al
    Childhood adversity and cortical thickness and surface area in a population at familial high risk of schizophrenia.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  127. VREEKER A, Boks MP, Abramovic L, Verkooijen S, et al
    High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  128. LEVINE SZ, Levav I, Goldberg Y, Pugachova I, et al
    Exposure to genocide and the risk of schizophrenia: a population-based study.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    November 2015
  129. KRAAN T, Velthorst E, Koenders L, Zwaart K, et al
    Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    July 2015
  130. VELING W, Susser E, Selten JP, Hoek HW, et al
    Social disorganization of neighborhoods and incidence of psychotic disorders: a 7-year first-contact incidence study.
    Psychol Med. 2015;45:1789-98.
    PubMed     Text format     Abstract available


    May 2015
  131. WICKHAM S, Sitko K, Bentall RP
    Insecure attachment is associated with paranoia but not hallucinations in psychotic patients: the mediating role of negative self-esteem.
    Psychol Med. 2015;45:1495-507.
    PubMed     Text format     Abstract available


    April 2015
  132. VELIKONJA T, Fisher HL, Mason O, Johnson S, et al
    Childhood trauma and schizotypy: a systematic literature review.
    Psychol Med. 2015;45:947-63.
    PubMed     Text format     Abstract available


  133. FETT AK, Shergill SS, Krabbendam L
    Social neuroscience in psychiatry: unravelling the neural mechanisms of social dysfunction.
    Psychol Med. 2015;45:1145-65.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: